Your session is about to expire
← Back to Search
Local Ablative Therapy for Non-Small Cell Lung Cancer
Study Summary
This trial will test whether a treatment that ablates (destroys) cancer cells when MRD levels are rising can control metastatic NSCLC better than systemic therapy.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I've had up to 4 rounds of initial cancer treatment.I don't have serious health issues that would prevent me from getting radiotherapy or ablation.I have health issues that prevent me from receiving radiation or ablation treatments.I had imaging tests done within 4 weeks of my blood test for cancer DNA.I haven't had any cancer except for skin cancer or a localized cancer that hasn't spread in the last year.I cannot have stereotactic radiotherapy due to physical limitations.I have 10 or fewer cancer spots that can be targeted with local treatment.You did not have a complete improvement in your condition on X-ray or imaging when you joined the treatment phase.I am 18 years old or older.I haven't had any cancer, except for skin cancer, in the last 5 years.I haven't had any cancer in the last year except for skin cancer or localized cancer that hasn't spread.I have at least one tumor that can be measured.I can safely undergo focused radiation treatment.My stage IV lung cancer shows signs in my blood tests.My cancer has not spread to the brain only.I am not scheduled for targeted therapy or considered for systemic treatment.I am set to receive targeted therapy or am not eligible for systemic therapy.There is no sign of tumor growth based on imaging tests.I am not able to become pregnant or I have a negative pregnancy test.Your test results for a certain gene mutation must be from within 4 weeks before joining the study.I am able to get out of my bed or chair and move around.I have had a condition where my lymphocytes grow abnormally.My organs are healthy enough for targeted radiation therapy.I have a history of cancer.I have completed at least 2 cycles of my first cancer treatment and am still on it.
- Group 1: Part I
- Group 2: Part II - standard of care
- Group 3: Part II - ablation to all sites of disease (experimental arm)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has the FDA sanctioned local ablative therapy?
"Local ablative therapy has been given a safety rating of 2 due to the limited data available from Phase 2 trials, which only support its safety rather than its efficacy."
How many participants are being included in this research program?
"Affirmative. According to clinicaltrials.gov, this research study is actively searching for volunteers and was posted on June 15th 2022 with its last update made November 17th 2022. A total of 117 subjects need to be enrolled from 7 different medical centres."
How many health centers are currently participating in this experiment?
"Patients can now enroll in this clinical trial at Memorial Sloan Kettering Westchester (Limited Protocol Activities) located in Harrison, as well as the New york and Basking Ridge branches of Memorial Sloan Kettering Cancer Center. Additionally, there are 7 other recruiting locations throughout the United States."
Are there any current opportunities to join this clinical trial?
"Affirmative. According to the details available on clinicaltrials.gov, this medical trial which was initially posted on June 15th 2022 is actively searching for 117 participants spread across 7 different sites."
Share this study with friends
Copy Link
Messenger